Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
Saved in:
| Title: | Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. |
|---|---|
| Authors: | Jørstad ØK; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway. OEYJOE@ous-hf.no., Foss S; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Gjølberg TT; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Mester S; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Nyquist-Andersen M; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Sivertsen MS; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway., Fossum D; The Hospital Pharmacy Oslo, Ullevål, Norway., Gleditsch E; The Hospital Pharmacy Oslo, Ullevål, Norway., Moe MC; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Andersen JT; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway. |
| Source: | International journal of retina and vitreous [Int J Retina Vitreous] 2023 Nov 07; Vol. 9 (1), pp. 65. Date of Electronic Publication: 2023 Nov 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101677897 Publication Model: Electronic Cited Medium: Print ISSN: 2056-9920 (Print) Linking ISSN: 20569920 NLM ISO Abbreviation: Int J Retina Vitreous Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37936232 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jørstad+ØK%22">Jørstad ØK</searchLink>; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway. OEYJOE@ous-hf.no.<br /><searchLink fieldCode="AU" term="%22Foss+S%22">Foss S</searchLink>; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gjølberg+TT%22">Gjølberg TT</searchLink>; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Mester+S%22">Mester S</searchLink>; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Nyquist-Andersen+M%22">Nyquist-Andersen M</searchLink>; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sivertsen+MS%22">Sivertsen MS</searchLink>; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Fossum+D%22">Fossum D</searchLink>; The Hospital Pharmacy Oslo, Ullevål, Norway.<br /><searchLink fieldCode="AU" term="%22Gleditsch+E%22">Gleditsch E</searchLink>; The Hospital Pharmacy Oslo, Ullevål, Norway.<br /><searchLink fieldCode="AU" term="%22Moe+MC%22">Moe MC</searchLink>; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Andersen+JT%22">Andersen JT</searchLink>; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101677897%22">International journal of retina and vitreous</searchLink> [Int J Retina Vitreous] 2023 Nov 07; Vol. 9 (1), pp. 65. <i>Date of Electronic Publication: </i>2023 Nov 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101677897 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2056-9920 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220569920%22">20569920 </searchLink><i>NLM ISO Abbreviation: </i>Int J Retina Vitreous <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37936232 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40942-023-00507-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 65 Titles: – TitleFull: Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jørstad ØK – PersonEntity: Name: NameFull: Foss S – PersonEntity: Name: NameFull: Gjølberg TT – PersonEntity: Name: NameFull: Mester S – PersonEntity: Name: NameFull: Nyquist-Andersen M – PersonEntity: Name: NameFull: Sivertsen MS – PersonEntity: Name: NameFull: Fossum D – PersonEntity: Name: NameFull: Gleditsch E – PersonEntity: Name: NameFull: Moe MC – PersonEntity: Name: NameFull: Andersen JT IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 11 Text: 2023 Nov 07 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2056-9920 Numbering: – Type: volume Value: 9 – Type: issue Value: 1 Titles: – TitleFull: International journal of retina and vitreous Type: main |
| ResultId | 1 |
